Health Affairs, 25, no. 5 (2006): w375-w377 (Published online 15 August 2006) doi: 10.1377/hlthaff.25.w375 © 2006 by Project HOPE	New Online   McAllen, TX & Beyond: An Expert Roundtable   Geography & Reform   Medicaid or Insurance Exchange?   Siren Song of New GME   Public Plan Option: Pro & Con

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kahn, J. Articles by Sankar, P. Search for Related Content PubMed PubMed Citation Articles by Kahn, J. Articles by Sankar, P.

Web Exclusives

PERSPECTIVE

Being Specific About Race-Specific Medicine

Gary Puckrein’s paper "BiDil: From Another Vantage Point" misrepresents rather than refutes our previously published analysis of BiDil. Puckrein claims that if our analysis were to prevail, patients would be denied life-saving therapy. Any reasonable reading of our paper suggests exactly the opposite. Indeed, based on the evidence, we urge doctors to prescribe the generics or BiDil itself as they see fit, but without regard to the race of their patient.

                      What's this?